compounded semaglutide glp-1 injections GLP-1s semaglutide compounding news fda FDA

Four in ten (41%) former users reported discontinuing treatment in 2026 because the medications were too expensive, making affordability the leading reason for stopping treatment

TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in actin polymerization and cellular motility

That one in 8 also covers a lot of diabetics who would be eating fewer calories than "normal" people even on conventional diabetes meds if they're following a program

Pure Med Spa Your partner in modern medical weight loss.

Especially when correctly preparing and storing peptides, the right set of tools is indispensable

doi: 10.2337/db15-1356 113 ZinmanBWannerCLachinJMFitchettDBluhmkiEHantelSet al